Home › NDC Lookup › RxCUI directory › RxCUI 1723187

8 ML ziv-aflibercept 25 MG/ML Injection — RxCUI 1723187

RxNorm drug concept · Semantic clinical drug
RxCUI 1723187 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1723187
Official name8 ML ziv-aflibercept 25 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asziv-aflibercept 200 MG per 8 ML Injection; ziv-aflibercept 200 MG in 8 ML Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aflibercept Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Right now, injecting aflibercept directly into the eye is the only way the medication works for these conditions. It needs to reach the retina in high enough concentrations to bloc...
  • Why do I need injections in my eye — is there any other way to take this?
  • It depends on your specific condition. For wet AMD and diabetic conditions, you'll typically start with monthly injections for a few months, and then your doctor will likely space...
  • How often will I need to come in for injections?
📖 Read our full Aflibercept Injection guide →

🕸️ Concept Web — How 8 ML ziv-aflibercept 25 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 8 ML ziv-aflibercept 25 MG/ML Injection RxCUI 1723187

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Aflibercept 1232150
    • Ziv-aflibercept 1304475
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zaltrap 1304480
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aflibercept Injection 1723180
    • Ziv-aflibercept Injection 2646478
    • Aflibercept Injectable Product 1232152
    • Ziv-aflibercept Injectable Product 2661349
    • Aflibercept Injection [Zaltrap] 1723188
    • Ziv-aflibercept Injection [Zaltrap] 2654698
    • Zaltrap Injectable Product 1304483
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ziv-aflibercept 25 MG/ML SCDC · 1304476
  • Aflibercept Injection SCDF · 1723180
  • Ziv-aflibercept Injection SCDFP · 2646478
  • Aflibercept Injectable Product SCDG · 1232152
  • Ziv-aflibercept Injectable Product SCDGP · 2661349

Brand-Name Concepts

  • 8 ML ziv-aflibercept 25 MG/ML Injection [Zaltrap] SBD · 1723189
  • Ziv-aflibercept 25 MG/ML [Zaltrap] SBDC · 1304481
  • Aflibercept Injection [Zaltrap] SBDF · 1723188
  • Ziv-aflibercept Injection [Zaltrap] SBDFP · 2654698
  • Zaltrap Injectable Product SBDG · 1304483
  • Zaltrap BN · 1304480

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1723187 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00024-5840-01 1 VIAL in 1 CARTON (0024-5840-01) / 4 mL in 1 VIAL ZALTRAP sanofi-aventis U.S. LLC 2012-08-03
00024-5841-01 1 VIAL in 1 CARTON (0024-5841-01) / 8 mL in 1 VIAL ZALTRAP sanofi-aventis U.S. LLC 2012-08-03
Observed labelers: sanofi-aventis U.S. LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9400 Inj, ziv-aflibercept, 1mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.